# Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures

> **NCT00640146** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Opioid-induced Constipation

## Interventions

- **DRUG:** Methylnaltrexone bromide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00640146
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-19
- **Primary completion:** 2009-01-21
- **Final completion:** 2009-01-21
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640146, "Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00640146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*